Ovid Therapeutics Operating Margin Growth & History (OVID)

Ovid Therapeutics's operating margin was −585.20% for fiscal 2025.

View full Ovid Therapeutics company overview

Ovid Therapeutics annual operating margin history

Ovid Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−585.20%+10348.54 pp
20242024-12-31−10,933.75%+4188.96 pp
20232023-12-31−15,122.70%−11426.27 pp
20222022-12-31−3,696.44%−3756.05 pp
20212021-12-3159.61%+705.00 pp
20202020-12-31−645.40%

Ovid Therapeutics operating margin trends

Over the last five reported fiscal years, Ovid Therapeutics's operating margin increased from −645.40% to −585.20%, a change of +60.19 percentage points. The latest reported quarter, Q2 2026, shows −2,141.61%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Ovid Therapeutics filings at SEC.gov ↗